Provectus Biopharmaceuticals Inc (PVCT)

[vorlon1966]

Patents protect ideas. In this case the idea is combining RB in a saline solution for use as a cancer treatment. It is well protected. In addition it has orphan drug status which is enforced by the FDA. That means no lawyers need to be involved in patent suits. If PVCT finds a company copying them then one phone call to the FDA brings the wrath of the federal government down on the copiers.....immediate shutdown.

Now lets talk about commercial RB already out there for staining corneal scratches and marking the liver. It is 95% pure....not high enough for oncology use by international standards. PVCT invented the process to make RB 99.9% pure....they own those patents.

What about similar molecules that could do the same thing?.....already thought up, mapped out and patented by PVCT. Nobody can invent anything close to this molecule that PVCT doesn't already own the patents on.

They have strong Kung Fu on drug innovation and patent protection.